Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 225-918-0 | CAS number: 5146-66-7
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Geranyl nitrile is likely to be non hazardous by oral, inhalation and dermal route of exposure.
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Data is from peer reviewed journal
- Qualifier:
- according to guideline
- Guideline:
- other: refer below principle
- Principles of method if other than guideline:
- The acute toxicity study has been performed on rats by oral route.
- GLP compliance:
- not specified
- Test type:
- other: no data
- Limit test:
- no
- Species:
- rat
- Strain:
- not specified
- Sex:
- not specified
- Details on test animals or test system and environmental conditions:
- No details available
- Route of administration:
- oral: unspecified
- Vehicle:
- not specified
- Details on oral exposure:
- No data
- Doses:
- No data
- No. of animals per sex per dose:
- No data
- Control animals:
- not specified
- Details on study design:
- No details available
- Statistics:
- No data
- Sex:
- not specified
- Dose descriptor:
- LD50
- Effect level:
- 3 100 mg/kg bw
- Based on:
- test mat.
- Remarks on result:
- other: 50 % mortaltiy
- Mortality:
- 50% mortality occurred
- Clinical signs:
- other: No data
- Gross pathology:
- No data
- Other findings:
- No data
- Interpretation of results:
- not classified
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- The LD50 value for test chemical Geranyl nitrile was found to be 3100 mg/kg when exposed to rat by oral route.
- Executive summary:
The acute toxicity study has been conducted on rats by oral route for the chemical Geranyl nitrile.The LD50 value was found to be 3100 mg/kg when exposed to rat by oral route.
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 3 100 mg/kg bw
- Quality of whole database:
- Data is Klimisch 2 and from peer-reviewed journal
Acute toxicity: via inhalation route
Link to relevant study records
- Endpoint:
- acute toxicity: inhalation
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Data is from peer reviewed journal and study report by Commission of the European Communities
- Qualifier:
- according to guideline
- Guideline:
- other: refer below principle
- Principles of method if other than guideline:
- Acute inhalation toxicity of chemical Geranyl nitrile in rats.
- GLP compliance:
- not specified
- Test type:
- other: no data
- Limit test:
- yes
- Species:
- rat
- Strain:
- not specified
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- No details available
- Route of administration:
- inhalation
- Type of inhalation exposure:
- nose/head only
- Vehicle:
- not specified
- Details on inhalation exposure:
- 4-hrs
- Analytical verification of test atmosphere concentrations:
- not specified
- Duration of exposure:
- 4 h
- Concentrations:
- 5.2 mg/L
- No. of animals per sex per dose:
- 10 male,10 female
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 4 days
- Frequency of observations and weighing:no data
- Necropsy of survivors performed: yes
- Other examinations performed: clinical signs, body weight,organ weights, histopathology - Statistics:
- No data available
- Preliminary study:
- No data available
- Sex:
- male/female
- Dose descriptor:
- LC50
- Effect level:
- > 5.2 mg/L air
- Based on:
- test mat.
- Exp. duration:
- 4 h
- Remarks on result:
- other: No mortality observed
- Mortality:
- No mortality were observed in treated male and female rats at 5.2 mg/L
- Clinical signs:
- other: During exposure aqueous discharge from noses and salivation, slight discharge from eyes, tips of noses, ears and limbs reddened. After exposure tips of noses reddened with limited loss of hair.
- Body weight:
- No data
- Gross pathology:
- After 4 days animals without findings,Necropsy revealed no abnormalities in sacrificed animals
- Other findings:
- No data
- Interpretation of results:
- practically nontoxic
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- LC 50 was considered to be > 5.2 m/L when male and female rats were treated with 3,7-Dimethylocta-2,6-dienenitrile by Liquid aerosol exposure in Head nose inhalation system for 4 hours.
- Executive summary:
In a acute inhalation toxicity study, male and female rats were treated with 3,7-Dimethylocta-2,6-dienenitrile in the concentration of 5.2 m/L by Liquid aerosol exposure in Head nose inhalation system for 4 hours. No effect on survival of treated male and female rats was observed at 5.2 m/L. During exposure aqueous discharge from noses and salivation, slight discharge from eyes, tips of noses, ears and limbs reddened. After exposure tips of noses reddened with limited loss of hair. After 4 days, no clinical sign were observed in treated rats. In addition, no gross pathological changes were observed in treated male and female rats. Therefore, LC 50 was considered to be > 5.2 m/L when male and female rats were treated with 3,7-Dimethylocta-2,6-dienenitrile by Liquid aerosol exposure in Head nose inhalation system for 4 hours.
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LC50
- Value:
- 520 mg/m³ air
- Quality of whole database:
- Data is Klimisch 2 and from peer-reviewed journal
Acute toxicity: via dermal route
Link to relevant study records
- Endpoint:
- acute toxicity: dermal
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Data is from peer reviewed journal
- Qualifier:
- according to guideline
- Guideline:
- other: refer below principle
- Principles of method if other than guideline:
- The acute toxicity study has been performed on rabbits by dermal route.
- GLP compliance:
- not specified
- Test type:
- other: no data
- Limit test:
- no
- Species:
- rabbit
- Strain:
- not specified
- Sex:
- not specified
- Details on test animals or test system and environmental conditions:
- No details available
- Type of coverage:
- not specified
- Vehicle:
- not specified
- Details on dermal exposure:
- no data
- Duration of exposure:
- no data
- Doses:
- 4300 mg/kg bw
- No. of animals per sex per dose:
- no data
- Control animals:
- not specified
- Details on study design:
- no data
- Statistics:
- no data
- Preliminary study:
- no data
- Sex:
- not specified
- Dose descriptor:
- LD50
- Effect level:
- 4 300 mg/kg bw
- Based on:
- test mat.
- Remarks on result:
- other: 50 % mortality
- Mortality:
- 50% mortality occurred
- Clinical signs:
- other: No data
- Gross pathology:
- No data
- Other findings:
- No data
- Interpretation of results:
- not classified
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- LD50 was considered to be 4300 mg/kg bw when rabbits were treated with Geranyl nitrile by dermal application.
- Executive summary:
In a acute dermal toxicity study, rabbits were treated with Geranyl nitrile in the concentration of 4300 mg/kg bw by dermal application. 50 % mortality observed in 4300 mg/kg bw treated rats. Therefore, LD50 was considered to be 4300 mg/kg bw when rabbits were treated with Geranyl nitrile by dermal application.
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 4 300 mg/kg bw
- Quality of whole database:
- Data is Klimisch 2 and from peer-reviewed journal
Additional information
Acute oral toxicity:
Based on the data available for target Geranyl nitrile (CAS no 5146-66-7) and its read across 3,7-Dimethyl-2,6-nonadienenitrile (CAS no 61792-11-8) and Citronellyl Nitrile (CAS no 51566-62-2) are summarized below
In a study given in monographs by Wohlet al(1976), acute oral toxicity was evaluated in rat by using Geranyl nitrile in the concentration of 3100 mg/kg bw orally. 50 % mortality observed in 3100 mg/kg bw treated rats. Therefore, LD50 was considered to be 3100 mg/kg bw when rat were treated with Geranyl nitrile orally.
Based on the prediction done by using QSAR Toolbox 3.4 (2016), acute oral toxicity was estimated in Wistar male and female rats by using geranyl nitrile orally. 50 % mortality observed in 3472.5 mg/kg bw treated rats. Therefore, estimated LD50 was considered to be 3472.5 mg/kg bw when Wistar male and female rats were treated with geranyl nitrile orally
In a study given in monographs by Morenoet al(1992) for read across, acute oral toxicity was evaluated rat by using 3,7-Dimethyl-2,6-nonadienenitrile in the concentration of 2600 mg/kg bw orally. 50 % mortality observed in 2600 mg/kg bw treated rats. Therefore, LD50 was considered to be 2600 mg/kg bw when rat were treated with 3,7-Dimethyl-2,6-nonadienenitrile orally.
In a study given in monographs by Morenoet al(1979 for read across), acute oral toxicity was evaluated rat by using Citronellyl Nitrile in the concentration of 5300 mg/kg bw orally. 50 % mortality observed in 5300 mg/kg bw treated rats. Therefore, LD50 was considered to be 5300 mg/kg bw (4200—6700) when rat were treated with Citronellyl Nitrile orally.
Thus, based on weight of evidence for target Geranyl nitrile (CAS no 5146-66-7) and its read across 3,7-Dimethyl-2,6-nonadienenitrile (CAS no 61792-11-8) and Citronellyl Nitrile (CAS no 51566-62-2) is likely to be non hazardous by oral route of exposure.
Acute inhalation toxicity:
Based on the data available for target Geranyl nitrile (CAS no 5146-66-7) are summarized below
In a study given by Brainet al(2007) and Commission of European Communities (2007), acute inhalation toxicity was evaluated in male and female rats by using 3,7-Dimethylocta-2,6-dienenitrile in the concentration of 5.2 m/L by Liquid aerosol exposure in Head nose inhalation system for 4 hours. No effect on survival of treated male and female rats was observed at 5.2 m/L. During exposure aqueous discharge from noses and salivation, slight discharge from eyes, tips of noses, ears and limbs reddened. After exposure tips of noses reddened with limited loss of hair. After 4 days, no clinical sign were observed in treated rats. In addition, no gross pathological changes were observed in treated male and female rats. Therefore, LC 50 was considered to be > 5.2 m/L when male and female rats were treated with 3,7-Dimethylocta-2,6-dienenitrile by Liquid aerosol exposure in Head nose inhalation system for 4 hours.
Based on the prediction done by using QSAR Toolbox 3.4 (2016), acute inhalation toxicity was estimated in Wistar male and female rats by using geranyl nitrile in the concentration of 3.4 m/L by aerosol exposure in Head nose inhalation system for 4 hours. 50 % effect on survival of treated male and female rats was observed at 3.4 m/L. Therefore, LC 50 was considered to be 3.4 m/L when Wistar male and female rats were treated with geranyl nitrile by Liquid aerosol exposure in Head nose inhalation system for 4 hours.
Thus, based on weight of evidence for target Geranyl nitrile (CAS no 5146-66-7) is likely to be non hazardous by inhalation route of exposure.
Acute dermal toxicity:
Based on the data available for target Geranyl nitrile (CAS no 5146-66-7) and its read across 3,7-Dimethyl-2,6-nonadienenitrile (CAS no 61792-11-8), 3-Methyl-2(3)-Nonenenitrile (CAS no 53153-66-5) and Citronellyl Nitrile (CAS no 51566-62-2) are summarized below
In a study given in monographs by Wohlet al(1976), acute dermal toxicity was evaluated in rabbits by using Geranyl nitrile in the concentration of 4300 mg/kg bw by dermal application. 50 % mortality observed in 4300 mg/kg bw treated rats. Therefore, LD50 was considered to be 4300 mg/kg bw when rabbits were treated with Geranyl nitrile by dermal application.
Based on the prediction done by using QSAR Toolbox 3.4 (2016), acute dermal toxicity was estimated in rabbits by using geranyl nitrile by dermal route. 50 % mortality observed in 2698.4 mg/kg bw treated rabbits. Therefore, estimated LD50 was considered to be 2698.4 mg/kg bw when rabbits were treated with geranyl nitrile by dermal route.
In a study given in monographs by Morenoet al(1992) for read across, acute dermal toxicity was evaluated in 10 rabbits by using 3,7-Dimethyl-2,6-nonadienenitrile in the concentration of 5000 mg/kg bw by dermal application. No mortality (0/10) was observed in 5000 mg/kg bw treated rabbits. Therefore, LD50 was considered to be > 5000 mg/kg bw when rabbits were treated with 3,7-Dimethyl-2,6-nonadienenitrile by dermal application.
In a study given in monographs by Morenoet al(1982) for read across, acute dermal toxicity was evaluated in rabbits by using 3-Methyl-2(3)-Nonenenitrile in the concentration of 5000 mg/kg bw by dermal application. No mortality was observed in 5000 mg/kg bw treated rabbits. Therefore, LD50 was considered to be > 5000 mg/kg bw when rabbits were treated with 2-Nonenenitrile, 3-methyl- by dermal application.
In a study given in monographs by Morenoet al(1979) for read across, acute dermal toxicity was evaluated in rabbits by using Citronellyl Nitrile in the concentration of 5000 mg/kg bw dermal application. No mortality observed in 5000 mg/kg bw treated rabbits. Therefore, LD50 was considered to be > 5000 mg/kg bw when rabbits were treated with Citronellyl Nitrile by dermal application.
Thus, based on weight of evidence for target Geranyl nitrile (CAS no 5146-66-7) and its read across 3,7-Dimethyl-2,6-nonadienenitrile (CAS no 61792-11-8), 3-Methyl-2(3)-Nonenenitrile (CAS no 53153-66-5) and Citronellyl Nitrile (CAS no 51566-62-2) is likely to be non hazardous by dermal route of exposure.
Justification for selection of acute toxicity – oral endpoint
LD50 was considered to be 3100 mg/kg bw when rat were treated with Geranyl nitrile orally.
Justification for selection of acute toxicity – inhalation endpoint
LC 50 was considered to be > 5.2 m/L when male and female rats were treated with 3,7-Dimethylocta-2,6-dienenitrile by Liquid aerosol exposure in Head nose inhalation system for 4 hours.
Justification for selection of acute toxicity – dermal endpoint
LD50 was considered to be 4300 mg/kg bw when rabbits were treated with Geranyl nitrile by dermal application.
Justification for classification or non-classification
Based on weight of evidence for target Geranyl nitrile (CAS no 5146-66-7) and its read across 3,7-Dimethyl-2,6-nonadienenitrile (CAS no 61792-11-8), 3-Methyl-2(3)-Nonenenitrile (CAS no 53153-66-5) and Citronellyl Nitrile (CAS no 51566-62-2) is likely to be non hazardous by oral, inhalation and dermal route of exposure.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.